- Home
- NGD vs BCPC Comparison
NGD vs BCPC Comparison
Compare NGD & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGD | BCPC |
|---|---|---|
| Founded | N/A | 1967 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.8B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | NGD | BCPC |
|---|---|---|
| Price | $8.85 | $154.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.75 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 16.1M | 222.4K |
| Earning Date | 02-18-2026 | 10-21-2025 |
| Dividend Yield | N/A | ★ 0.61% |
| EPS Growth | ★ 1232.42 | 22.48 |
| EPS | 0.31 | ★ 4.57 |
| Revenue | ★ $1,242,200,000.00 | $1,013,548,000.00 |
| Revenue This Year | $62.14 | $10.41 |
| Revenue Next Year | $57.44 | $5.89 |
| P/E Ratio | ★ $28.22 | $34.26 |
| Revenue Growth | ★ 44.19 | 7.55 |
| 52 Week Low | $2.43 | $139.17 |
| 52 Week High | $9.59 | $177.40 |
Technical Indicators
Market Signals| Indicator | NGD | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 47.72 |
| Support Level | $8.68 | $155.62 |
| Resistance Level | $9.52 | $158.59 |
| Average True Range (ATR) | 0.51 | 3.54 |
| MACD | 0.03 | -0.09 |
| Stochastic Oscillator | 64.16 | 49.20 |
Price Performance
Historical ComparisonAbout NGD New Gold Inc.
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets which are also its operating segments: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.
About BCPC Balchem Corporation
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.